| P50 | author | Cemal Cingi | Q57168875 |
| | Nuray Bayar Muluk | Q89554735 |
| P2093 | author name string | Kagan Ipci | |
| | Niyazi Altıntoprak | |
| | Mehmet Senturk | |
| P2860 | cites work | Prebiotics in infants for prevention of allergy | Q24199115 |
| | Probiotics for preventing acute upper respiratory tract infections | Q24234353 |
| | Human gut microbiome viewed across age and geography | Q24602950 |
| | Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 |
| | Antibiotics in early life alter the murine colonic microbiome and adiposity | Q24630877 |
| | Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine | Q24648636 |
| | A core gut microbiome in obese and lean twins | Q24649648 |
| | Hay fever, hygiene, and household size | Q24674856 |
| | Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps | Q27006760 |
| | Effect of barrier microbes on organ-based inflammation | Q27693228 |
| | Innate immune recognition | Q27860721 |
| | The microbiome in asthma | Q28080434 |
| | Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 |
| | Minireview: Gut microbiota: the neglected endocrine organ | Q28241240 |
| | Low diversity of the gut microbiota in infants with atopic eczema | Q28254907 |
| | The causes of intestinal dysbiosis: a review | Q28272103 |
| | Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 |
| | The gut microbiota--masters of host development and physiology | Q28286102 |
| | Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial | Q28287413 |
| | Therapeutic potential of fecal microbiota transplantation | Q28298108 |
| | Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 |
| | Induction of colonic regulatory T cells by indigenous Clostridium species | Q29547701 |
| | Functional interactions between the gut microbiota and host metabolism | Q29616815 |
| | The impact of the gut microbiota on human health: an integrative view | Q29617446 |
| | Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section | Q30221761 |
| | The role of the bacterial microbiome in lung disease | Q33554623 |
| | Influences of microbiota on intestinal immune system development | Q33610638 |
| | Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways | Q33618756 |
| | Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders | Q33719638 |
| | Intestinal microbial diversity during early-life colonization shapes long-term IgE levels | Q33725722 |
| | Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children | Q34117961 |
| | Patterns of early gut colonization shape future immune responses of the host | Q34221994 |
| | Delivery by Cesarean section and early childhood respiratory symptoms and disorders: the Norwegian mother and child cohort study | Q34228719 |
| | Molecular monitoring of the development of intestinal microbiota in Japanese infants | Q34298658 |
| | NALT- versus Peyer's-patch-mediated mucosal immunity | Q34345343 |
| | House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection | Q34392336 |
| | Diet, metabolites, and "western-lifestyle" inflammatory diseases | Q34425867 |
| | Rhinosinusitis and asthma-microbiome and new perspectives | Q34467796 |
| | Asthma and atopy in children born by caesarean section: effect modification by family history of allergies - a population based cross-sectional study | Q34478164 |
| | Chapter 12: Human microbiome analysis | Q34539646 |
| | Commensal bacteria protect against food allergen sensitization | Q34583618 |
| | IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans | Q34614781 |
| | γ-Aminobutyric acid production by culturable bacteria from the human intestine. | Q34638462 |
| | Diversity of intestinal microbiota in infancy and the risk of allergic disease in childhood. | Q34645808 |
| | Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. | Q34649546 |
| | Asthma microbiome studies and the potential for new therapeutic strategies | Q34741123 |
| | Microbiota regulates immune defense against respiratory tract influenza A virus infection | Q34750186 |
| | A meta-analysis of the association between Caesarean section and childhood asthma. | Q34763124 |
| | Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection | Q34943083 |
| | The microbiome of the upper airways: focus on chronic rhinosinusitis | Q35012395 |
| | Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health | Q35024885 |
| | Low gut microbiota diversity in early infancy precedes asthma at school age. | Q35065097 |
| | Gut microbiota and allergic disease: new findings | Q35096170 |
| | The gut microbiota and its role in the development of allergic disease: a wider perspective | Q35158619 |
| | Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 |
| | Microbiome diversity and asthma and allergy risk | Q35230090 |
| | The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies | Q35539468 |
| | The microbiota: an exercise immunology perspective | Q35590851 |
| | Intestinal microbiota and allergic diseases: A systematic review. | Q35634317 |
| | Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host | Q35710101 |
| | Gut immune maturation depends on colonization with a host-specific microbiota | Q36235223 |
| | Probiotic therapy as a novel approach for allergic disease | Q36250265 |
| | The 'microflora hypothesis' of allergic diseases | Q36360555 |
| | Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis | Q36673558 |
| | Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months | Q36698632 |
| | Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper | Q36834812 |
| | The human microbiome. Early life determinant of health outcomes | Q37679755 |
| | A brave new world: the lung microbiota in an era of change | Q37679757 |
| | Regulation of inflammatory responses by the commensal microbiota | Q37913736 |
| | Microbes and mucosal immune responses in asthma. | Q38083320 |
| | The prenatal environment and type 1 diabetes | Q38105282 |
| | The common mucosal immune system and current strategies for induction of immune responses in external secretions | Q39663021 |
| | Probiotic effects on cold and influenza-like symptom incidence and duration in children | Q40383184 |
| | The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction | Q42442755 |
| | Caesarean delivery, caesarean delivery on maternal request and childhood overweight: a Chinese birth cohort study of 181 380 children | Q43983018 |
| | Probiotics in primary prevention of allergic disease--follow-up at 8-9 years of age. | Q45388230 |
| | Maternal and infant outcome after caesarean section without recorded medical indication: findings from a Swedish case-control study | Q46321202 |
| | No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. | Q50787321 |
| | Reduced diversity in the early fecal microbiota of infants with atopic eczema. | Q50858770 |
| | Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. | Q51019555 |
| | Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students. | Q51037111 |
| | Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. | Q53117636 |
| | Temporal variations in early gut microbial colonization are associated with allergen-specific immunoglobulin E but not atopic eczema at 2 years of age. | Q54357257 |
| | Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood | Q56968869 |
| | Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses | Q58590807 |
| | Altered early infant gut microbiota in children developing allergy up to 5 years of age | Q58590854 |
| | Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort | Q61841407 |
| | Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) | Q70823350 |
| | The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? | Q77591396 |
| | Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients | Q84030790 |
| | Early probiotic supplementation for allergy prevention: long-term outcomes | Q84948139 |
| | The immunostimulant OM-85 BV prevents wheezing attacks in preschool children | Q85155651 |
| | The impact of perinatal immune development on mucosal homeostasis and chronic inflammation | Q95421092 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | European Archives of Oto-Rhino-Laryngology | Q2624005 |
| P1476 | title | The possible mechanisms of the human microbiome in allergic diseases | |